HungaryHungary

GMO crops ploughed under

09.08.2011

Budapest/Kraków – In July, illegally planted genetically modified crops made headlines in Hungary, where GMO acreage is banned. Up to 0.1% GMO maize products from Monsanto and Pioneer were discovered at four sites (near Szigetvar, Letavertes, Szolnok and Fejer county). This despite a new regulation that came into effect last March stipulating seed checks, and in spite of the law that seed firms are obliged to check seeds for GMOs before shipping.
In mid-July, Deputy State Secretary Lajos Bognar from the Hungarian Ministry of Rural Development ordered that the affected crops be destroyed. An area of about 1,000 hectares was affected, and it remains as yet unclear if other seeds provided to farmers by a Hungarian seed distributor and planted on an additional 2,500 hectares also contained GM maize. The farmers, who were unaware they were planting GMOs, said they stand to lose their complete harvest because it’s now too late to sow maize again this year. Monsanto has denied any responsibility, saying that every conventional seed batch is checked for GMO admixture before it is shipped. Monsanto has refused to pay any compensation to farmers, but has told the government the company will buy back any seeds it thinks are “GMO-infected”. It looks unlikely that farmers will receive any compensation, because the Hungarian distributor is under liquidation, and any possible damages will be paid primarily to its creditors.

Polish fear new legislation sets stage for flood of GMOs

At the end of July, hundreds of GMO protestors hit the street in Warsaw and Kraków to demonstrate against a new seed act, later passed by the Sejm, which aims to adjust Polish regulations to EU directives. Critics say the act indirectly creates a loophole that allows farmers to circumvent the existing marketing and cultivation ban by allowing GMO seeds to enter the national seed registry and to be imported from abroad.

HungaryHungary

05.03.2012

It was a great month for Gedeon Richter Nyrt. (Budapest). At the beginning of February, Hungary’s largest drugmaker announced positive outcomes for two late-stage Phase III trials. In a study sponsored by development partner...

HungaryHungary

09.08.2011

Budapest/Macclesfield – UK-headquartered global ADME-Tox specialist Cyprotex plc has partnered up with Solvo Bio­tech sro to provide the Hungarian firm’s drug transporter assays to its customers in the bio­pharmaceutical...

HungaryHungary

04.04.2011

Budapest – Hungarian vaccine developer Genetic Immunity Kft. (GI) has secured a cash injection of US$25m by signing an agreement with the Budapest-based technology commercialisation company Power of the Dream Ventures, Inc. The...

HungaryHungary

06.02.2011

Budapest/Tokyo – Hungary’s largest drugmaker Gedeon Richter Nyrt. has secured access to the Japanese market for its biosimilar pipeline. In mid-December, Richter CEO Erik Bogsch announced his company had signed a long-term...

HungaryHungary

03.11.2010

Budapest – Richter Group has bagged Swiss gynecology and infertility specialist Preg­Lem Holding SA in a 100 % equity stake worth up to EUR 359m. Hungary’s largest drugmaker expects PregLem’s lead candi­date Esmya as...

HungaryHungary

16.09.2010

Budapest – Hungary’s largest drugmaker Gedeon Richter Ltd. and US partner Forest Laboratory said that a Phase II clinical trial of their orally active drug cariprazine (RGH-188) for bipolar depression produced no “statistically...

HungaryHungary

01.07.2010

Budapest – New results from researchers at the Department of Pathology and Experimental Cancer Research in Budapest suggest that expression of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) on the surface of chronic...

HungaryHungary

01.02.2010

Budapest – ChemAxon, a specialist for chemical informatics software for the life sciences industry, has entered into an agreement with Pfizer. Under the terms of the agreement, Chemaxon will provide its Markush searching and...

HungaryHungary

30.12.2009

Budapest/Zug/Edinburgh – Swiss/Hungarian antibody specialist ImmunoGenes has inked a collaboration and license agreement with the Scottish Roslin Institute to develop specialised sheep that use ImmunoGenes’ proprietary technology...

Displaying results 1 to 10 out of 89

1-10 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-hungary/article/gmo-crops-ploughed-under.html

Events

All Events

Partner-Events

Santiago de Compostela (ES)

BioSpain 2014

Stock list

All quotes

TOP

  • WILEX2.35 EUR5.86%
  • FORMYCON8.19 EUR2.37%
  • SARTORIUS96.09 EUR2.22%

FLOP

  • THERAMETRICS0.08 CHF-11.11%
  • MAGFORCE7.05 EUR-3.42%
  • ACTELION109.20 CHF-2.59%

TOP

  • PAION3.26 EUR31.5%
  • EPIGENOMICS3.80 EUR22.6%
  • CO.DON3.04 EUR21.6%

FLOP

  • ADDEX3.19 CHF-20.2%
  • CYTOS0.21 CHF-19.2%
  • MEDIGENE3.85 EUR-17.2%

TOP

  • SANTHERA87.00 CHF2075.0%
  • PAION3.26 EUR246.8%
  • CO.DON3.04 EUR230.4%

FLOP

  • CYTOS0.21 CHF-94.7%
  • THERAMETRICS0.08 CHF-42.9%
  • 4SC1.12 EUR-41.4%

No liability assumed, Date: 23.09.2014


Current issue

All issues

Product of the week

Products